New Hepatitis C Drug SIMEPREVIR being... - HepCBC Hepatitis ...

HepCBC Hepatitis C Education & Prevention Society

New Hepatitis C Drug SIMEPREVIR being reviewed in Canada-needs patient input

Cheryl-HepCBC profile image
Cheryl-HepCBCHepCBC
0 Replies

HepCBC Hepatitis C Education & Prevention Society needs input from Canadians who are HCV+ and their caregivers, for its patient group submission to the Canadian Drug Review (CADTH). New drug being reviewed: simeprevir (similar to boceprevir and telaprevir, but only one pill per day and does not require special food intake). Deadline: midnight, Sept. 11, 2013. Give input at: hepcbc.ca/2013/08/urgent-re... . THANKS!

Written by
Cheryl-HepCBC profile image
Cheryl-HepCBC
HepCBC
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.